References
- Hayes D F. We may be lost, but we're sure makin good time. Cancer Invest 1993; 11: 88
- Goldin A, Venditti J M, Humphrys S R, Mantel N. Influences of concentration of leukemic inoculum on the effectiveness of treatment. Science 1956; 123: 840
- Skipper H E, Schabel FM, Jr, Wilcox W S. Experimental evaluation of potential anticancer agents. XIII. On the criteria and kinetics associated with “curability” of experimental leukemia. Cancer Chemother Rep 1964; 35: 1
- Martin D S, Fugmann R A, Hayworth P. Surgery. cancer chemotherapy, host defenses. and tumor size. J Nat Cancer inst 1962; 29: 817
- Law L W. Effects of combinations of antileukemic agents on an acute lymphocytic leukemia of mice. Cancer Res 1952; 12: 871
- Henderson E S, Samaba R J. Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res 1969; 29: 2272
- Griswold D P, Schabel FM, Jr, Corbett T H, Dykes D J. Concepts for controlling drug-resistant tumor cells. Design of Models for Testing Cancer Therapeutic Agents, I J Fidler, R J White. Van Nostrand Reinhold, New York 1982; 215–224
- Holland J F, Glidewell. Oncologists' reply: Survival expectancy in acute lymphocytic leukemia. N Engl J Med 1972; 287: 769–777
- Fisher B, Slack N H. and cooperating investigators: Number of lymph nodes examined and the prognosis of breast cancer. Surg Gynecol Obstet 1970; 131: 79
- Bhardwaj S, Holland J F, Norton L. An intensive sequenced adjuvant chemotherapy for breast cancer. Cancer Invest 1993; 11: 6–9
- Fisher B, Osborne C K, Margolese R, Bloomer W. Neoplasms of the breast. Cancer Medicine, 3rd ed, J F Holland, E Frei, III, RC Bast, Jr, D W Kufe, D L Morton, R R Weichselbaum. Lea & Febiger, Philadelphia 1993; 1706–1774
- Early Breast Cancer Trialists' Collaborative Group. Systemic treatment of early breast cancer by hormonal cytotoxic or immune therapy. Lancet 1992; 339: 1–15; 71–85
- Bhardwaj S, Cirrincione C T, Berry D. CALGB 1993, Unpublished observations